Filing status
- Accounts due
- 31 December 2026
- Last accounts
- 31 December 2024
- Conf. stmt due
- 29 March 2027
- Last conf. stmt
- 15 March 2026
Icon Clinical Research (U.K.) No. 2 Limited
- Incorporated
- 30 July 2013 (13 years)
- Previously known as
- Mapi Life Sciences UK Limited (until 19 April 2021)Optum Life Sciences (UK) Limited (until 14 July 2015)Optum Health & Technology Limited (until 11 July 2014)
- Industry
- Other human health activities (86900)
- Directors
- Emer Mcelhinney
- Accounts type
- Full
- Region
- South East
- Address
- 3rd FloorNorth & South Wings 100 Longwater AvenueGreen ParkReadingRG2 6GP
Charges
- Total
- 1
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 1
Officers 3 active
Officer details are public data from the Companies House register.
Mcelhinney, Emer
Director · Appointed 31 August 2026
Irish
Born August 1979 (47)
Fox, Erina, Ms.
Secretary · Appointed 27 July 2017
Director · Appointed 27 July 2017
British
Born December 1966 (59)
Officer history (10 former)
31 August 2026
Appointed Mcelhinney, Emer as Director
8 April 2026
Resigned Sheehan, Alan as Director
21 October 2022
8 June 2018
1 December 2017
Resigned Blazei, Alan Steven as Director
27 July 2017
Resigned Page, Nigel Granville as Secretary
27 July 2017
Appointed Fox, Erina, Ms. as Secretary
27 July 2017
Appointed Sheehan, Alan as Director
27 July 2017
27 July 2017
Resigned Karis, James Michael as Director
27 July 2017
24 August 2016
30 December 2014
Appointed Karis, James Michael as Director
30 December 2014
Appointed Page, Nigel Granville as Secretary
30 December 2014
Appointed Blazei, Alan Steven as Director
30 December 2014
30 December 2014
30 December 2014
Resigned Spicola, Brigid as Secretary
5 September 2014
15 January 2014
15 January 2014
30 July 2013
30 July 2013
Appointed Spicola, Brigid as Secretary
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 31 May 2025
Owns 75–100% of shares
Holds 75–100% of voting rights
Private Limited Company
Reg. no. 02541764
Former controllers (4)
31 May 2025
Ceased Icon Clinical Research (U.K.) No. 3 Limited — Owns 75–100% of shares
19 July 2017
19 July 2017
Ceased James Karis — Has significant influence or control (as a trust)
19 July 2017
Ceased Alan Blazei — Has significant influence or control
Group structure 10 companies
Ownership group derived from the Companies House PSC register
Icon Clinical Research (U.K.) Limited Owns 50–75% of shares
Aptiv Solutions (UK) Ltd Owns 75–100% of shares
Docs International UK Limited Owns 75–100% of shares
Icon Clinical (UK) Limited Owns 75–100% of shares
Imp Logistics UK Limited Owns 75–100% of shares
Icon Clinical Research (U.K.) No. 2 Limited This company Owns 75–100% of shares
Icon Clinical Research (U.K.) No. 3 Limited Owns 75–100% of shares
Icon Development Solutions Limited Owns 75–100% of shares
VSK (Kenilworth) Limited Owns 75–100% of shares
Filings 83
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 28 September 2026 | Appointment of a director | |||
| 13 May 2026 | Termination of appointment of a director | |||
| 21 April 2026 | Confirmation statement with updates | 15 March 2026 | ||
| 30 January 2026 | Auditor's resignation | |||
| 7 January 2026 | Full accounts | 31 December 2024 |
Some other companies at this address
Other companies in this industry
Newcastle Upon Tyne
Wokingham
Birmingham
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →